Takako Nagao

4PUBLICATIONS
8CO-AUTHORS
Gene and molecular therapyDisease surveillancePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 16, 2026
Real-World Safety and Effectiveness of Cabotegravir in People Living with HIV: Interim Report of a Post-marketing Surveillance in Japan.

|Mar 30, 2026
Safety and Effectiveness Analysis of Dolutegravir and Dolutegravir/Abacavir/Lamivudine in Japanese People Living with HIV: 10 years of Post-Marketing Surveillance.

Akemi Sebata, Takako Nagao, Tomoko Matsukawa

|Feb 25, 2023
Safety and Effectiveness Analyses of Dolutegravir/Lamivudine in Patients with HIV: 2-Year Report of Post-Marketing Surveillance in Japan.

Ayano Tofukuji, Haruyuki Hongo, Takako Nagao

|Jul 18, 2021
Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan.

Haruyuki Hongo, Takako Nagao, Kyoko Nakamura

Pageof 1

Frequent Collaborators

4 joint publications

Akiko Fukuda

2 joint publications

Haruyuki Hongo

2 joint publications

Akemi Sebata

2 joint publications

Yuko Maeno